Celgene competitorsClear all

Celgene's top competitors include BioNTech, Sanofi, Idorsia, Amgen, Gilead Sciences and Regeneron Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Celgene
Celgene
Celgene is a biopharmaceutical company developing therapies for the treatment of cancer and inflammatory diseases.
BioNTech
BioNTech
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Founding Date
Founding Date
1986
Founding Date
2008
Founding Date
2004
Founding Date
2017
Founding Date
1980
Founding Date
1987
Founding Date
1988
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
Mainz, DE HQ
Halle (Saale), DE
Idar Oberstein, DE
Marburg, DE
Neuried, DE
Planegg, DE
Cambridge, US
see more
Locations
Paris, FR HQ
Hydra, DZ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
see more
Locations
Allschwil, CH HQ
Shanghai, CN
Lörrach, DE
Chiyoda City, JP
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Machelen, BE
Santo Amaro, BR
see more
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Bernards, US
Rensselaer, US
Sleepy Hollow, US
see more
Employees
Employees
8,85219% increase
Employees
1,94149% increase
Employees
95,4424% decrease
Employees
8007% increase
Employees
24,200
Employees
14,4006% increase
Employees
10,36814% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
39.8 b
Valuation ($)
138 b
Valuation ($)
N/A
Valuation ($)
139.4 b
Valuation ($)
80.1 b
Valuation ($)
71.1 b
Twitter followers
Twitter followers
26.8 k
Twitter followers
77.7 k
Twitter followers
147.9 k
Twitter followers
1.8 k
Twitter followers
105.4 k
Twitter followers
70.8 k
Twitter followers
31.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
101
Number of tweets (last 30 days)
26
Number of tweets (last 30 days)
24
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
76
Average likes per tweet (last 30 days)
16.3
Average likes per tweet (last 30 days)
6.3
Average likes per tweet (last 30 days)
6.2
Average likes per tweet (last 30 days)
175.8
Average likes per tweet (last 30 days)
7.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
95.05%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
95.83%
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
180054
Alexa Website Rank
178741
Alexa Website Rank
149324
Alexa Website Rank
181163
Alexa Website Rank
128868
Alexa Website Rank
139075
Employee Rating
Employee Rating
4
Employee Rating
3.3
Employee Rating
N/A
Employee Rating
3.9
Employee Rating
4.1
Employee Rating
N/A
Employee Rating
4.1

Financial

Revenue (est.)
Revenue (est.)
$15.3b (FY, 2018)
Revenue (est.)
€108.6m (FY, 2019)
Revenue (est.)
€37.8b (FY, 2021)
Revenue (est.)
CHF35.3m (FY, 2021)
Revenue (est.)
$26b (FY, 2021)
Revenue (est.)
$27.3b (FY, 2021)
Revenue (est.)
$16.1b (FY, 2021)
Cost of goods
Cost of goods
$587m (FY, 2018)
Cost of goods
(€15.9m) (FY, 2019)
Cost of goods
(€10.7b) (FY, 2021)
Cost of goods
N/A
Cost of goods
$6.5b (FY, 2021)
Cost of goods
$6.6b (FY, 2021)
Cost of goods
$2.4b (FY, 2021)
Gross profit
Gross profit
$14.7b (FY, 2018)
Gross profit
€95.5m (FY, 2019)
Gross profit
€28.9b (FY, 2021)
Gross profit
CHF35.3m (FY, 2021)
Gross profit
$19.5b (FY, 2021)
Gross profit
$20.7b (FY, 2021)
Gross profit
$13.6b (FY, 2021)
Net income
Net income
$4b (FY, 2018)
Net income
(€179.2m) (FY, 2019)
Net income
€6.2b (FY, 2021)
Net income
(CHF634.6m) (FY, 2021)
Net income
$5.9b (FY, 2021)
Net income
$6.2b (FY, 2021)
Net income
$8.1b (FY, 2021)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
100 (FY, 2020)
Countries
35 (FY, 2020)
Countries
N/A
Patents (EU)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
21 (FY, 2020)
Patents (EU)
N/A
Patents (EU)
17 (FY, 2020)
Patents (US)
Patents (US)
N/A
Patents (US)
45 (Oct, 2019)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
650 (Dec, 2020)
Patents (US)
31 (FY, 2020)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
8 (Oct, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
9 (FY, 2021)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
7 (FY, 2019)
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
1 (Oct, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
12 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
3 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
8 (FY, 2020)
Phase III Trials Products
N/A
Products
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
20 (FY, 2020)
Products
7 (FY, 2020)
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
12 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.4b
Total funding raised
$ 310m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 8.9m
For sources of this data, please see the company profile

View company profiles

BioNTech
HQ
Mainz, DE
Employees
1,941↑ 49% increase

BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.

View company
Sanofi
HQ
Paris, FR
Employees
95,442↓ 4% decrease

Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.

View company
Idorsia
HQ
Allschwil, CH
Employees
800↑ 7% increase

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.

View company
Amgen
HQ
Thousand Oaks, US
Employees
24,200

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company